Zuberitamab

A4DAB309 | Cancer | Phase-II
MS4A1/CD20
G1 / IgG1
Zhejiang Hisun Pharmaceutical
Phase-II
Whole mAb
HS-006 HS006 HS 006 RHCACD20MA
—
IMGT PubChem (103771410) PubChem (405023478) PubChem (472422269) PubChem (476262831) PubChem (476269368) Thera-SAbDab YAbS
Avg A4D Score
-0.6649
Score Range
-0.66
Structures
1
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity

Associated Structural Profiles Level 2

Structure ID Source PDB Seq. Identity Avg. A4D Score pH (Min Agg.) pH (Max Agg.) Score CDR Score non-CDR
A4DAB309_3bky_H_L 3bky 96% -0.6649 6.5 9.0 -0.1647 -0.7263